Abbott
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
Published in Healthcare Mergers, Acquisitions and Ventures Week, August 1st, 2009
the high end of Abbott's second-quarter guidance range of $0.87 to
$0.89. Diluted earnings per share under Generally Accepted Accounting
Principles (GAAP) were $0.83. -- Worldwide operational sales, which excludes an unfavorable 8.0 percent
effect of exchange rates, increased 10.5 percent. Reported sales,
including the impact of exchange, increased 2.5 percent. Excluding the
expected decline in Depakote sales...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 911 Enable
E911 Support Now Available for Avaya SIP Phones - A.D.A.M., Inc.
CallMD Selects A.D.A.M. Multimedia Encyclopedia for Its Innovative Physician Service - Aaron Klein for WorldNetDaily.com
'Terrorist Leader' Fuming Mad Over 'Bruno' Movie - AARP Illinois
Older Illinoisans Struggling In Recession May Be Missing Out On Help Paying for Food - Abdominal Aortic Aneurysm
Society for Vascular Nursing Releases Patient Care Guideline: Published in June Issue of Journal of Vascular Nursing - Abitibibowater INC. - English
AbitibiBowater Announces New Executive Team Structure - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
